Top Raleigh, NC Health Tech Companies With Best Stability & Growth (89)
.png)
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is using the power of high-intensity sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to enhance the scientific understanding of cancer biology, and to develop and commercialize pioneering products.
GRAIL's Top Stability & Growth Strengths
Strong Revenue Growth: Revenue is rising at a double‑digit pace across 2025 and into 2026, with consistent year‑over‑year gains. Galleri test volumes and screening revenue also increased, signaling sustained commercial momentum.
Market Expansion: Access is broadening through major EHR integrations and a growing provider network, alongside initiatives to enter new geographies. These moves extend reach beyond core channels and support continued adoption.
Investor Backing & Capital Strength: Capital raises and a sizable cash position provide a multi‑year runway to fund commercialization, trials, and regulatory efforts. Strategic financings with prominent partners reinforce the ability to invest through scale‑up.
Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments for people with unmet medical needs. As a leading innovator of Digital Therapeutics™, Click delivers accessible, clinically proven, FDA-regulated prescription treatments to the smartphone in your hand. Click’s treatments are defined by a commitment to applying technical and scientific rigor and patient-centric design to the development process. This...
Click Therapeutics's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent financing includes a $50 million Series D anchored by Boehringer Ingelheim, following a Series C in 2025 and prior debt financing, indicating sustained access to strategic capital. The transfer of CT-155 commercialization responsibility alongside dedicated commercial funding further underscores capital support aligned with near-term growth plans.
Strategic Partnerships: Collaborations with major pharmaceutical companies such as Otsuka and Boehringer Ingelheim, alongside agreements with Indivior and Ultrahuman, reflect deepening partner engagement in development and commercialization. These alliances have produced FDA-authorized products and structured milestone and royalty pathways that reinforce external validation.
Product Line Growth: Multiple FDA authorizations (Rejoyn for MDD and CT-132 for migraine), the acquisition of AspyreRx, and an expanded pipeline spanning psychiatry, neurology, and cardiometabolic disease point to a broader, more mature portfolio. Positive Phase 3 results and commercialization preparations for CT-155 add momentum to this expansion.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
By the year 2050, the number of people in the U.S. age 65 and over will swell to almost 90 million, about twice the current population. For over 20 years, TheKey has helped clients achieve long-term aging at home with comprehensive, concierge-based care. As the leading private pay home care provider in the nation, TheKey is continuing to address this...
At Mallinckrodt, we use strategic vision and employee-driven momentum to pursue a powerful mission: Listening for needs and delivering solutions. As a leader in specialty pharmaceuticals, we develop, manufacture, market and distribute innovative treatments for underserved patient populations within neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal...
The National MS Society is a non-profit organization dedicated to curing multiple sclerosis while empowering people affected by the disease to live their best lives through research, education, and support.
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with...
Roche's Top Stability & Growth Strengths
Strong Market Position & Advantage: Roche is the global leader in in‑vitro diagnostics and remains a top‑tier biopharma with a significant oncology footprint. The dual Pharmaceuticals–Diagnostics model is a strategic differentiator at scale.
Strong Revenue Growth: Group sales rose 7% at constant exchange rates in 2025 and 6% at CER in Q1 2026, with both divisions contributing. Guidance for 2026 indicates continued mid–single‑digit CER growth.
Profitability: Profitability improved in 2025 alongside sales, with higher IFRS net income and core EPS growth. Management pointed to capacity to keep investing while rewarding shareholders.
Lane & Associates Family Dentistry is a North Carolina born and bred company. Beginning in Fuquay-Varina in 1980, Dr. Don Lane has since expanded our reach to over 50 locations throughout North Carolina. We can be found in major cities like Raleigh, Durham, Cary, & Greensboro but we can also be found in small towns such as Biscoe, Erwin, Hamlet...
Luna is a leading in-home, tech-enabled physical therapy platform that provides 1:1 personalized care. By shifting treatment from the clinic to the home, the company improves accessibility, convenience, and patient outcomes. Luna leverages proprietary technology like Auto-Charting® to streamline documentation for therapists, allowing them to focus on patient care. The company partners with major health systems and is covered by...
Aledade is the largest network of independent primary care, enabling clinicians to deliver better patient outcomes and generate more savings revenue through value-based care. Aledade’s data, personal coaching, user-friendly workflows, health care policy expertise, strong payer relationships and integrated care solutions enable primary care organizations to succeed financially by keeping people healthy. Together with more than 1,900 practices and community...
Aledade's Top Stability & Growth Strengths
Strong Market Position & Advantage: Aledade is positioned as a category leader in value-based care enablement for independent primary care, supported by its large national network and repeated references to outsized influence in Medicare ACO participation and savings outcomes.
Investor Backing & Capital Strength: The company is described as having substantial funding and financing capacity, including major equity rounds and a large senior secured credit facility intended to support scaling and working-capital needs.
Market Expansion: The organization is described as expanding rapidly in geographic footprint and partner counts, with continued additions of new primary care organizations across dozens of states and growth in covered patient lives.
Navion Senior Solutions is a leader in senior living, dedicated to delivering exceptional care through assisted living, independent living, and memory care services. The company operates from a perspective of continuous quality improvement, focusing on enriching the lives of its residents and employees. With a commitment to providing comprehensive support, Navion manages numerous communities to ensure high-quality living experiences for...
Sunnybrook Rehabilitation Center is a rehabilitation facility located in Raleigh that provides a caring environment to meet rehabilitation and nursing needs, aiming to help patients return to their prior level of function.
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities. We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. Together...
Syneos Health's Top Stability & Growth Strengths
Strong Market Position & Advantage: Company materials and third‑party recognition portray a fully integrated CRO/CCO with leadership status, including widespread involvement in recent FDA/EMA novel therapies and recognition as a leading pharmacovigilance provider.
Strategic Partnerships: Recent collaborations with Microsoft and KX are positioned to enable AI‑driven efficiencies across clinical and commercial operations, with reported improvements in cycle times supporting operational scalability.
Investor Backing & Capital Strength: The 2025 take‑private by investment groups (including Elliott and Veritas) provides financial sponsorship to pursue tech‑enabled growth and operational repositioning.
Intelerad is a leader enterprise workflow and medical image archiving solutions for all types of healthcare organizations. Renowned for their innovative features and functionality, Intelerad solutions, such as InteleViewer™ and InteleOne® XE, increase productivity and streamline workflow by overcoming technical barriers in distributed and complex environments. Highly scalable, flexible and robust, Intelerad’s solutions offer high performance and industry leading customer...
Align Technology is a global medical device company focused on digital orthodontics and restorative dentistry. It designs, manufactures, and sells the Invisalign clear-aligner system, iTero intraoral scanners, and exocad CAD/CAM software. Its platform combines 3D modeling, biomechanical shape engineering, mass customization, and 3D printing to support doctors, dental practices, laboratories, and patients with integrated digital treatment workflows.
Since 2001, we've been building an industrial-strength health information network designed to increase patient safety, lower costs and improve quality of care. THE SURESCRIPTS NETWORK ALLIANCE® Built to Transform Interactions between Clinicians, Pharmacists and Patients The Surescripts Network Alliance unites virtually all electronic health records (EHR) vendors, pharmacy benefit managers (PBMs), pharmacies and clinicians, plus an increasing number of health plans, long-term and...
Interim HealthCare - Great Lakes Health Partners delivers home health, hospice, and palliative care services across the Midwest, offering personalized care plans and compassionate caregivers.
Carolina Outreach is a North Carolina behavioral health provider serving children, families, and adults. It offers comprehensive, integrative services including behavioral health care, therapy, substance-use treatment, crisis support, wellness programs, and teletherapy. Founded on a families-first, strengths-based model, the organization aims to promote emotional and physical well-being, help clients develop their strengths, and improve quality of life in inclusive, respectful...
ProPharma is the premier Research Consulting Organization (RCO), delivering fully customizable consulting solutions to empower biotech, med device, and pharmaceutical organizations of all sizes to advance scientific breakthroughs confidently and introduce new therapies. With over 20 years of expertise in regulatory sciences, clinical research solutions, quality & compliance, pharmacovigilance, medical information, and R&D technology, ProPharma partners with clients across the...
Verily is an Alphabet company combining a data-driven, people-first approach to bring the promise of precision health to everyone, every day. We are focused on generating and applying evidence from a wide variety of sources to change the way people manage their health and the way healthcare is delivered - shifting the paradigm from “one size fits all” medicine to...
Verily's Top Stability & Growth Strengths
Investor Backing & Capital Strength: Recent $300M financing in March 2026, conversion to a C‑corp, and Alphabet remaining a significant minority investor indicate strong capital access to scale its AI‑native precision health platform. Earlier large rounds and ongoing backing provide resources for expansion while pursuing independence.
Product Line Growth: The company has expanded offerings with the AI‑native Pre platform (including opening Exchange and Workbench self‑serve/free tiers), the Verily Me app, and the Lightpath Metabolic program positioned for broad availability in 2026. These launches and migrations from Onduo signal a cohesive product strategy aimed at broader adoption.
Strategic Partnerships: Partnerships with NVIDIA, Samsung, UCHealth/CU Anschutz, and NIH “All of Us” via Vanderbilt, plus CMS ACCESS model participation, point to growing ecosystem traction. These collaborations expand research and care use cases and distribution channels.
